Irish Nabriva Therapeutics plc has acquired San Diego-based antibiotics developer Zavante Therapeutics for 8.2...
Up To Date
Latest News
US gene editing expert Sangamo Therapeutics is set to acquire French biotech TxCell in an all-cash buyout of...
Swedish Orphan Biovitrum AB (Sobi) has signed a €387 deal with Swiss drug developer Novimmune for a late stage...
European biotechs Morphosys and Galapagos have handed over their joint atopical dermatitis programme MOR106 to...
The Innovative Medicines Initiative has launched a new Antimicrobial Resistance Accelerator Programme after...
Roche announced today that the US-American Food and Drug Administration FDA has granted Breakthrough Therapy...